{"id":"https://openalex.org/W2011188338","doi":"https://doi.org/10.1073/pnas.0711839105","title":"Evidence for a role of the 5-HT 1B receptor and its adaptor protein, p11, in l -DOPA treatment of an animal model of Parkinsonism","display_name":"Evidence for a role of the 5-HT 1B receptor and its adaptor protein, p11, in l -DOPA treatment of an animal model of Parkinsonism","alternate_titles":[],"publication_year":2008,"publication_date":"2008-02-12","ids":{"openalex":"https://openalex.org/W2011188338","doi":"https://doi.org/10.1073/pnas.0711839105","mag":"2011188338","pmid":"https://pubmed.ncbi.nlm.nih.gov/18256188","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2538893"},"language":"en","primary_location":{"id":"doi:10.1073/pnas.0711839105","doi":"https://doi.org/10.1073/pnas.0711839105","is_oa":false,"landing_page_url":"https://doi.org/10.1073/pnas.0711839105","pdf_url":null,"source":{"id":"https://openalex.org/S125754415","display_name":"Proceedings of the National Academy of Sciences","issn_l":"0027-8424","issn":["0027-8424","1091-6490"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320052","host_organization_name":"National Academy of Sciences","host_organization_lineage":["https://openalex.org/P4310320052"],"host_organization_lineage_names":["National Academy of Sciences"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Proceedings of the National Academy of Sciences","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2011188338"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2538893/","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5052123856","display_name":"Xiaoqun Zhang","orcid":"https://orcid.org/0000-0002-2723-4451","observed_orcids":["https://orcid.org/0000-0002-2723-4451"]},"institutions":[{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Xiaoqun Zhang","raw_affiliation_strings":["*Section of Translational Neuropharmacology, Department of Physiology and Pharmacology, Karolinska Institute, 17177 Stockholm, Sweden; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"*Section of Translational Neuropharmacology, Department of Physiology and Pharmacology, Karolinska Institute, 17177 Stockholm, Sweden; and","institution_ids":["https://openalex.org/I28166907"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068745437","display_name":"Per E. Andr\u00e9n","orcid":"https://orcid.org/0000-0002-4062-7743","observed_orcids":["https://orcid.org/0000-0002-4062-7743"]},"institutions":[{"id":"https://openalex.org/I123387679","display_name":"Uppsala University","ror":"https://ror.org/048a87296","country_code":"SE","type":"education","lineage":["https://openalex.org/I123387679"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Per E. Andren","raw_affiliation_strings":["Laboratory for Biological and Medical Mass Spectrometry, Uppsala University, 75123 Uppsala, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory for Biological and Medical Mass Spectrometry, Uppsala University, 75123 Uppsala, Sweden","institution_ids":["https://openalex.org/I123387679"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052825834","display_name":"Paul Greengard","orcid":"https://orcid.org/0000-0002-4437-0893","observed_orcids":["https://orcid.org/0000-0002-4437-0893"]},"institutions":[{"id":"https://openalex.org/I83399316","display_name":"Rockefeller University","ror":"https://ror.org/0420db125","country_code":"US","type":"education","lineage":["https://openalex.org/I83399316"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Paul Greengard","raw_affiliation_strings":["Laboratory of Molecular and Cellular Neuroscience, The Rockefeller University, New York, NY10021;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Molecular and Cellular Neuroscience, The Rockefeller University, New York, NY10021;","institution_ids":["https://openalex.org/I83399316"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5036364090","display_name":"Per Svenningsson","orcid":"https://orcid.org/0000-0001-6727-3802","observed_orcids":["https://orcid.org/0000-0001-6727-3802"]},"institutions":[{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]},{"id":"https://openalex.org/I83399316","display_name":"Rockefeller University","ror":"https://ror.org/0420db125","country_code":"US","type":"education","lineage":["https://openalex.org/I83399316"]}],"countries":["SE","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Per Svenningsson","raw_affiliation_strings":["*Section of Translational Neuropharmacology, Department of Physiology and Pharmacology, Karolinska Institute, 17177 Stockholm, Sweden; and","Laboratory of Molecular and Cellular Neuroscience, The Rockefeller University, New York, NY10021;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"*Section of Translational Neuropharmacology, Department of Physiology and Pharmacology, Karolinska Institute, 17177 Stockholm, Sweden; and","institution_ids":["https://openalex.org/I28166907"]},{"raw_affiliation_string":"Laboratory of Molecular and Cellular Neuroscience, The Rockefeller University, New York, NY10021;","institution_ids":["https://openalex.org/I83399316"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":8.4914,"has_fulltext":false,"cited_by_count":125,"citation_normalized_percentile":{"value":0.98203155,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"105","issue":"6","first_page":"2163","last_page":"2168"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9688000082969666,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9688000082969666,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.027499999850988388,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10919","display_name":"Deep Brain Stimulation and Movement Disorders","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/5-ht1b-receptor","display_name":"5-HT1B receptor","score":0.9559999704360962},{"id":"https://openalex.org/keywords/p11","display_name":"p11","score":0.9300000071525574},{"id":"https://openalex.org/keywords/serotonin","display_name":"serotonin","score":0.625},{"id":"https://openalex.org/keywords/l-dopa","display_name":"L-DOPA","score":0.8109999895095825},{"id":"https://openalex.org/keywords/parkinson-s-disease","display_name":"Parkinson's disease","score":0.9700000286102295},{"id":"https://openalex.org/keywords/6-ohda-lesion","display_name":"6-hydroxydopamine lesion","score":0.8700000047683716},{"id":"https://openalex.org/keywords/striatonigral-neurons","display_name":"striatonigral neurons","score":0.781000018119812},{"id":"https://openalex.org/keywords/dopamine-d1-receptor","display_name":"dopamine D1 receptor","score":0.7300000190734863},{"id":"https://openalex.org/keywords/negative-feedback","display_name":"negative feedback","score":0.6129999756813049},{"id":"https://openalex.org/keywords/involuntary-movements","display_name":"involuntary movements","score":0.902999997138977},{"id":"https://openalex.org/keywords/rotational-behavior","display_name":"rotational behavior","score":0.8140000104904175},{"id":"https://openalex.org/keywords/dopaminergic-denervation","display_name":"dopaminergic denervation","score":0.5559999942779541}],"concepts":[{"id":"https://openalex.org/C2780938664","wikidata":"https://www.wikidata.org/wiki/Q753278","display_name":"Substantia nigra","level":4,"score":0.7621923685073853},{"id":"https://openalex.org/C2780062018","wikidata":"https://www.wikidata.org/wiki/Q1319792","display_name":"Striatum","level":3,"score":0.7314516305923462},{"id":"https://openalex.org/C37000724","wikidata":"https://www.wikidata.org/wiki/Q50430226","display_name":"Serotonergic","level":4,"score":0.6877756118774414},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.6466301679611206},{"id":"https://openalex.org/C2776525014","wikidata":"https://www.wikidata.org/wiki/Q1531991","display_name":"Parkinsonism","level":3,"score":0.5958662629127502},{"id":"https://openalex.org/C53910766","wikidata":"https://www.wikidata.org/wiki/Q238516","display_name":"5-HT receptor","level":4,"score":0.5754724740982056},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.5641418695449829},{"id":"https://openalex.org/C137183658","wikidata":"https://www.wikidata.org/wiki/Q461076","display_name":"Dopaminergic","level":3,"score":0.5581066012382507},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.5182664394378662},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.5061852335929871},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.48248934745788574},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4287448525428772},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.423403799533844},{"id":"https://openalex.org/C120069818","wikidata":"https://www.wikidata.org/wiki/Q415496","display_name":"Dopamine receptor","level":3,"score":0.4121329188346863},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3302538990974426},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.32833972573280334},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.29333195090293884},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.07346776127815247}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001345","descriptor_name":"Autoradiography","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001552","descriptor_name":"Benzazepines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D003342","descriptor_name":"Corpus Striatum","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003342","descriptor_name":"Corpus Striatum","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D007150","descriptor_name":"Immunohistochemistry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007980","descriptor_name":"Levodopa","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007980","descriptor_name":"Levodopa","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008807","descriptor_name":"Mice, Inbred BALB C","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010302","descriptor_name":"Parkinson Disease, Secondary","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D012333","descriptor_name":"RNA, Messenger","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D016627","descriptor_name":"Oxidopamine","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017366","descriptor_name":"Serotonin Receptor Agonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D018345","descriptor_name":"Mice, Knockout","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018492","descriptor_name":"Dopamine Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D044302","descriptor_name":"Receptor, Serotonin, 5-HT1B","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D044302","descriptor_name":"Receptor, Serotonin, 5-HT1B","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1073/pnas.0711839105","doi":"https://doi.org/10.1073/pnas.0711839105","is_oa":false,"landing_page_url":"https://doi.org/10.1073/pnas.0711839105","pdf_url":null,"source":{"id":"https://openalex.org/S125754415","display_name":"Proceedings of the National Academy of Sciences","issn_l":"0027-8424","issn":["0027-8424","1091-6490"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320052","host_organization_name":"National Academy of Sciences","host_organization_lineage":["https://openalex.org/P4310320052"],"host_organization_lineage_names":["National Academy of Sciences"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Proceedings of the National Academy of Sciences","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:2538893","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2538893/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Proc Natl Acad Sci U S A","raw_type":"Text"},{"id":"pmid:18256188","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18256188","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Proceedings of the National Academy of Sciences of the United States of America","raw_type":"Journal Article"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:2538893","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2538893/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Proc Natl Acad Sci U S A","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9476000070571899,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G4236631009","display_name":"Signaling Mechanisms Underlying Neuroleptic Drug Actions","funder_award_id":"P50MH074866","funder_id":"https://openalex.org/F4320337346","funder_display_name":"National Institute of Mental Health"},{"id":"https://openalex.org/G5778380521","display_name":"DRUGS OF ABUSE - ROLE OF PROTEIN PHOSPHORYLATION","funder_award_id":"P01DA010044","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"}],"funders":[{"id":"https://openalex.org/F4320322581","display_name":"Vetenskapsr\u00e5det","ror":"https://ror.org/03zttf063"},{"id":"https://openalex.org/F4320337346","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08"},{"id":"https://openalex.org/F4320337347","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":41,"referenced_works":["https://openalex.org/W62603772","https://openalex.org/W175006040","https://openalex.org/W249845531","https://openalex.org/W1522048223","https://openalex.org/W1533056363","https://openalex.org/W1867285585","https://openalex.org/W1966443363","https://openalex.org/W1971698832","https://openalex.org/W1977312832","https://openalex.org/W1987194328","https://openalex.org/W1991603311","https://openalex.org/W1992633971","https://openalex.org/W2002255217","https://openalex.org/W2009330496","https://openalex.org/W2028727583","https://openalex.org/W2033092161","https://openalex.org/W2035286056","https://openalex.org/W2039237085","https://openalex.org/W2046929321","https://openalex.org/W2055244807","https://openalex.org/W2061036786","https://openalex.org/W2062319694","https://openalex.org/W2067776617","https://openalex.org/W2070290419","https://openalex.org/W2076937644","https://openalex.org/W2078747341","https://openalex.org/W2085622756","https://openalex.org/W2086483799","https://openalex.org/W2086554492","https://openalex.org/W2092634694","https://openalex.org/W2095509348","https://openalex.org/W2097863680","https://openalex.org/W2136541816","https://openalex.org/W2140463558","https://openalex.org/W2163815564","https://openalex.org/W2254815352","https://openalex.org/W2401073808","https://openalex.org/W2403349133","https://openalex.org/W2411507408","https://openalex.org/W2416871384","https://openalex.org/W2952854120"],"related_works":["https://openalex.org/W1997483903","https://openalex.org/W2970686919","https://openalex.org/W1082767973","https://openalex.org/W1599468872","https://openalex.org/W2024525350","https://openalex.org/W2032093270","https://openalex.org/W1971779448","https://openalex.org/W2097863680","https://openalex.org/W2062891712","https://openalex.org/W2268294112"],"abstract_inverted_index":{"Parkinson's":[0],"disease":[1],"(PD)":[2],"is":[3,34],"characterized":[4],"by":[5,22,42],"a":[6,35,103,118],"progressive":[7],"degeneration":[8],"of":[9,19,26,39,53,76,102,136],"substantia":[10],"nigra":[11],"dopaminergic":[12],"neurons":[13,44],"projecting":[14],"to":[15,67],"the":[16,40,74,77,129,134],"striatum.":[17],"Restoration":[18],"dopamine":[20],"transmission":[21],"L-DOPA":[23,65],"relieves":[24],"symptoms":[25],"PD":[27],"but":[28],"causes":[29],"prominent":[30],"side":[31],"effects.":[32],"There":[33],"strong":[36],"serotonin":[37,130],"innervation":[38,55],"striatum":[41],"serotonergic":[43],"that":[45,63,100],"remains":[46],"relatively":[47],"preserved":[48],"in":[49,85,117],"PD.":[50],"The":[51],"study":[52],"this":[54],"has":[56],"been":[57],"largely":[58],"neglected.":[59],"Here,":[60],"we":[61],"demonstrate":[62],"chronic":[64],"administration":[66,101],"6-OHDA-lesioned":[68,91],"rodents":[69],"increases,":[70],"via":[71],"D1":[72],"receptors,":[73],"levels":[75],"5-HT1B":[78,105],"receptor":[79,106],"and":[80,94,113],"its":[81],"adaptor":[82],"protein,":[83],"p11,":[84],"dopamine-denervated":[86],"striatonigral":[87],"neurons.":[88],"Using":[89],"unilaterally":[90],"p11":[92],"WT":[93],"KO":[95],"mice,":[96],"it":[97],"was":[98],"found":[99],"selective":[104],"agonist,":[107],"CP94253,":[108],"inhibited":[109],"L-DOPA-induced":[110,125],"rotational":[111],"behavior":[112],"abnormal":[114],"involuntary":[115],"movements":[116],"p11-dependent":[119],"manner.":[120],"These":[121],"data":[122],"reveal":[123],"an":[124],"negative-feedback":[126],"mechanism,":[127],"whereby":[128],"system":[131],"may":[132],"influence":[133],"symptomatology":[135],"Parkinsonism.":[137]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2011188338","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":11},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":12},{"year":2014,"cited_by_count":12},{"year":2013,"cited_by_count":8},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
